Literature DB >> 24371773

Large granular lymphocytic leukemia associated with Lambert-Eaton Myasthenic Syndrome: A case report.

Richard Lemal1, Carine Chaleteix1, Patrice Minard2, Corinne Roche3, Jacques-Olivier Bay1, Olivier Tournilhac1, Thierry Lamy4.   

Abstract

Large granular lymphocytic (LGL) leukemia is an uncommon clonal lymphoproliferative disorder. Lambert-Eaton Myasthenic Syndrome (LEMS) is a rare neuromuscular autoimmune disease caused by pathogenic autoantibodies targeting the voltage-gated calcium channels (VGCC) on the presynaptic nerve terminal. We here describe the case of a 77-year old patient with LGL leukemia, associated with a seropositive and symptomatic LEMS and a seronegative rheumatoid arthritis. LGL leukemia treatment clearly improved LEMS symptoms, and led to anti-VGCC antibodies value decrease. To our knowledge, this is the first ever described association between LGL leukemia and LEMS.

Entities:  

Keywords:  LGL leukemia; Lambert–Eaton Myasthenic Syndrome; Large granular lymphocytic leukemia

Year:  2013        PMID: 24371773      PMCID: PMC3850575          DOI: 10.1016/j.lrr.2013.02.004

Source DB:  PubMed          Journal:  Leuk Res Rep        ISSN: 2213-0489


  12 in total

1.  [Hodgkin's disease with systemic vasculitis and Lambert-Eaton myasthenic syndrome--case report].

Authors:  W Homenda; A Hellmann
Journal:  Wiad Lek       Date:  2000

2.  Chronic myeloid leukaemia and a myasthenic syndrome.

Authors:  M A Wohl; J K Wood
Journal:  Acta Haematol       Date:  1979       Impact factor: 2.195

3.  Regulatory T cells in paraneoplastic neurological syndromes.

Authors:  Takashi Tani; Keiko Tanaka; Jiro Idezuka; Masatoyo Nishizawa
Journal:  J Neuroimmunol       Date:  2008-05-01       Impact factor: 3.478

4.  Lambert-Eaton myasthenic syndrome: tumor versus nontumor forms.

Authors:  Maarten J Titulaer; Jan J G M Verschuuren
Journal:  Ann N Y Acad Sci       Date:  2008       Impact factor: 5.691

5.  Distinct evolution of calcium channel antibody types in Lambert-Eaton myasthenic syndrome.

Authors:  Nicole Martin-Moutot; Luc De Haro; Michael Seagar
Journal:  J Neuroimmunol       Date:  2008-05-13       Impact factor: 3.478

Review 6.  Adenocarcinoma of the prostate and Eaton-Lambert syndrome. A previously unreported association.

Authors:  S K Agarawal; B R Birch; G F Abercrombie
Journal:  Scand J Urol Nephrol       Date:  1995-09

Review 7.  The root of many evils: indolent large granular lymphocyte leukaemia and associated disorders.

Authors:  Ranran Zhang; Mithun Vinod Shah; Thomas P Loughran
Journal:  Hematol Oncol       Date:  2010-09       Impact factor: 5.271

8.  Screening for small-cell lung cancer: a follow-up study of patients with Lambert-Eaton myasthenic syndrome.

Authors:  Maarten J Titulaer; Paul W Wirtz; Luuk N A Willems; Klaas W van Kralingen; Peter A E Sillevis Smitt; Jan J G M Verschuuren
Journal:  J Clin Oncol       Date:  2008-09-10       Impact factor: 44.544

9.  [Eaton-Lambert syndrome associated with multiple myeloma: resolution of the neuromuscular block after chemotherapy].

Authors:  C Portha; J L Dupond; G Monnier; J F Bosset; R Leconte des Floris
Journal:  Sem Hop       Date:  1983-04-28

Review 10.  Lambert-Eaton myasthenic syndrome (LEMS) in association with lymphoproliferative disorders.

Authors:  Z Argov; Y Shapira; L Averbuch-Heller; I Wirguin
Journal:  Muscle Nerve       Date:  1995-07       Impact factor: 3.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.